Alterity Therapeutics Limited Stock: price and insider trades · Australia
Alterity Therapeutics Limited: what insiders have been doing
Every trade that managers of Alterity Therapeutics Limited disclose to ASX is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 25 October 2026, brought 3 filings signed by 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of Alterity Therapeutics Limited has been absent for the past year.
Across the 1,596 companies tracked on its exchange, the median is 4 filings; at 3 filings, this issuer sits below that mark.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Source: insider filings from ASX. Past trades are no guide to future returns.
Financial data
as of FY 2026FY ended June 2026 · cache
- ShareASXISIN AU0000043945ASX:2924-03105268-3A696183
- ●Executives0ASX
- ShareASXASX:2924-03082004-3A691894
3 of 3 declarations
About Alterity Therapeutics Limited
Alterity Therapeutics Limited is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
